| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $24.24 ▲ +1.41% | Yesterday | $23.76 ▼ -0.59% | Tomorrow's Lyell Immunopharma Inc. Common Stock (LYEL) setup is anchored to $23.91 and targets $24.24 (+1.41%). The near-term read is upside; watch $24.62 / $23.19 because daily realized volatility is about 7.29%. |
Tomorrow's Lyell Immunopharma Inc. Common Stock (LYEL) setup is anchored to $23.91 and targets $24.24 (+1.41%). The near-term read is upside; watch $24.62 / $23.19 because daily realized volatility is about 7.29%. | ||||
| Week | $24.96 ▲ +4.40% | Last Week | $23.46 ▼ -1.85% | The 7-day Lyell Immunopharma Inc. Common Stock model moves from $23.46 to $24.96 (+4.40%). It gives upside momentum context for this stock, so breaks around $24.62 / $23.19 matter more than a single tick. |
The 7-day Lyell Immunopharma Inc. Common Stock model moves from $23.46 to $24.96 (+4.40%). It gives upside momentum context for this stock, so breaks around $24.62 / $23.19 matter more than a single tick. | ||||
| Month | $26.15 ▲ +9.37% | Last Month | $22.96 ▼ -3.94% | The 1-month Lyell Immunopharma Inc. Common Stock target is $26.15 (+9.37%), compared with the live reference near $23.91. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Lyell Immunopharma Inc. Common Stock target is $26.15 (+9.37%), compared with the live reference near $23.91. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $27.93 ▲ +16.82% | Last Year | $22.22 ▼ -7.07% | The 1-year Lyell Immunopharma Inc. Common Stock scenario points to $27.93 (+16.82%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Lyell Immunopharma Inc. Common Stock scenario points to $27.93 (+16.82%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $32.10 ▲ +34.29% | 5 Years Ago | $20.46 ▼ -14.40% | The 5-year Lyell Immunopharma Inc. Common Stock view is $32.10 (+34.29%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Lyell Immunopharma Inc. Common Stock view is $32.10 (+34.29%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $23.91 | Mid |
| Daily Change | -3.96% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 66% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $23.91 | Daily Change | -3.96% |
| Market Cap | $557.67M | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.